Sharechat Logo

EROAD Limited (NZX: ERD) Receives Overseas Investment Office Consent

Tuesday 9th November 2021

Text too small?

Transportation technology services company EROAD (NZX/ASX: ERD) announced today that it has received consent from New Zealand’s Overseas Investment Office (OIO) to acquire 100% of the shares in Coretex Limited.

The consent is granted subject to the OIO’s standard conditions, including that the consent holder and directors of EROAD must remain suitable to invest in New Zealand.

Following receipt of the OIO’s consent, the remaining key condition for EROAD’s acquisition of Coretex is obtaining clearance from the New Zealand Commerce Commission. As announced on 19 October, the Commerce Commission is currently considering further submissions from the parties to its statement of issues and EROAD remains confident the acquisition will complete before the end of 2021.

EROAD’s financial results for the six months ended 30 September 2021 will be released on 26 November 2021 to the NZX and the ASX.

Please see the link below for details

EROAD Receives Overseas Investment Office Consent

Source: EROAD Limited

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

Trade Window Holdings Limited (NZX: TWL) TradeWindow and Mastercard teams up
Genesis Energy Limited (NZX: GNE) FY22 Q2 Performance Report
Seeka Limited (NZX: SEK) Seeka announces dividend of 13 cents per share
20th January 2022 Morning Report
Z Energy Limited (NZX: ZEL) Q3FY33 Operating Data
Smartpay Holdings Limited (NZX: SPY) Trading Update
Rua Bioscience Limited (NZX: RUA) Shareholders Approve Zalm Therapeutics Share Issue
Harmoney Corp Limited (NZX: HMY) HMY achieves cash NPAT profitability in 1HFY22
19th January 2022 Morning Report
PaySauce Limited (NZX: PYS) Quarterly Market Update Dec 2021